499 related articles for article (PubMed ID: 27895587)
41. Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-Mψ-Nuclear Factor-κB-Nod-Like Receptor Protein 3 Pathway via gut-Liver Axis in Mice.
Bao T; He F; Zhang X; Zhu L; Wang Z; Lu H; Wang T; Li Y; Yang S; Wang H
Front Pharmacol; 2020; 11():558525. PubMed ID: 33390939
[No Abstract] [Full Text] [Related]
42. Gut-Specific Delivery of T-Helper 17 Cells Reduces Obesity and Insulin Resistance in Mice.
Hong CP; Park A; Yang BG; Yun CH; Kwak MJ; Lee GW; Kim JH; Jang MS; Lee EJ; Jeun EJ; You G; Kim KS; Choi Y; Park JH; Hwang D; Im SH; Kim JF; Kim YK; Seoh JY; Surh CD; Kim YM; Jang MH
Gastroenterology; 2017 Jun; 152(8):1998-2010. PubMed ID: 28246016
[TBL] [Abstract][Full Text] [Related]
43. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
[TBL] [Abstract][Full Text] [Related]
44. Beneficial Effects of Newly Isolated
Yang M; Bose S; Lim S; Seo J; Shin J; Lee D; Chung WH; Song EJ; Nam YD; Kim H
Microorganisms; 2020 Sep; 8(9):. PubMed ID: 32937828
[TBL] [Abstract][Full Text] [Related]
45. Antrodia cinnamomea reduces obesity and modulates the gut microbiota in high-fat diet-fed mice.
Chang CJ; Lu CC; Lin CS; Martel J; Ko YF; Ojcius DM; Wu TR; Tsai YH; Yeh TS; Lu JJ; Lai HC; Young JD
Int J Obes (Lond); 2018 Feb; 42(2):231-243. PubMed ID: 28630461
[TBL] [Abstract][Full Text] [Related]
46. Prolyl Endopeptidase Gene Disruption Improves Gut Dysbiosis and Non-alcoholic Fatty Liver Disease in Mice Induced by a High-Fat Diet.
Jiang D; Zhang J; Lin S; Wang Y; Chen Y; Fan J
Front Cell Dev Biol; 2021; 9():628143. PubMed ID: 34095107
[TBL] [Abstract][Full Text] [Related]
47. The combination of Ilexhainanoside D and ilexsaponin A
Zhao W; Xiao M; Yang J; Zhang L; Ba Y; Xu R; Liu Z; Zou H; Yu P; Wu X; Chen X
Phytomedicine; 2019 Oct; 63():153039. PubMed ID: 31387054
[TBL] [Abstract][Full Text] [Related]
48. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe
Zhu L; Zhang D; Zhu H; Zhu J; Weng S; Dong L; Liu T; Hu Y; Shen X
Atherosclerosis; 2018 Jan; 268():117-126. PubMed ID: 29202334
[TBL] [Abstract][Full Text] [Related]
49. Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota.
Zhou D; Pan Q; Shen F; Cao HX; Ding WJ; Chen YW; Fan JG
Sci Rep; 2017 May; 7(1):1529. PubMed ID: 28484247
[TBL] [Abstract][Full Text] [Related]
50. The Synbiotic Combination of
Juárez-Fernández M; Porras D; Petrov P; Román-Sagüillo S; García-Mediavilla MV; Soluyanova P; Martínez-Flórez S; González-Gallego J; Nistal E; Jover R; Sánchez-Campos S
Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943104
[TBL] [Abstract][Full Text] [Related]
51. The Therapeutic Efficacy of Curcumin vs. Metformin in Modulating the Gut Microbiota in NAFLD Rats: A Comparative Study.
Li R; Yao Y; Gao P; Bu S
Front Microbiol; 2020; 11():555293. PubMed ID: 33584555
[TBL] [Abstract][Full Text] [Related]
52. Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.
Gao L; Wang PX; Zhang Y; Yu CJ; Ji Y; Wang X; Zhang P; Jiang X; Jin H; Huang Z; Zhang ZR; Li H
J Hepatol; 2016 Jul; 65(1):125-136. PubMed ID: 27032381
[TBL] [Abstract][Full Text] [Related]
53. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
Shen SH; Zhong TY; Peng C; Fang J; Lv B
BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
[TBL] [Abstract][Full Text] [Related]
54. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
Jiang C; Xie C; Li F; Zhang L; Nichols RG; Krausz KW; Cai J; Qi Y; Fang ZZ; Takahashi S; Tanaka N; Desai D; Amin SG; Albert I; Patterson AD; Gonzalez FJ
J Clin Invest; 2015 Jan; 125(1):386-402. PubMed ID: 25500885
[TBL] [Abstract][Full Text] [Related]
55. Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives.
Han Y; Li L; Wang B
Front Med; 2022 Oct; 16(5):667-685. PubMed ID: 36318353
[TBL] [Abstract][Full Text] [Related]
56. Geniposide and Chlorogenic Acid Combination Ameliorates Non-alcoholic Steatohepatitis Involving the Protection on the Gut Barrier Function in Mouse Induced by High-Fat Diet.
Peng JH; Leng J; Tian HJ; Yang T; Fang Y; Feng Q; Zhao Y; Hu YY
Front Pharmacol; 2018; 9():1399. PubMed ID: 30618733
[TBL] [Abstract][Full Text] [Related]
57. High-Fat Diet Induces Dysbiosis of Gastric Microbiota Prior to Gut Microbiota in Association With Metabolic Disorders in Mice.
He C; Cheng D; Peng C; Li Y; Zhu Y; Lu N
Front Microbiol; 2018; 9():639. PubMed ID: 29686654
[TBL] [Abstract][Full Text] [Related]
58. Polyphenol- and Caffeine-Rich Postfermented Pu-erh Tea Improves Diet-Induced Metabolic Syndrome by Remodeling Intestinal Homeostasis in Mice.
Gao X; Xie Q; Kong P; Liu L; Sun S; Xiong B; Huang B; Yan L; Sheng J; Xiang H
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29061705
[TBL] [Abstract][Full Text] [Related]
59. Vitamin D alleviates non-alcoholic fatty liver disease
Zhang XL; Chen L; Yang J; Zhao SS; Jin S; Ao N; Yang J; Liu HX; Du J
Front Microbiol; 2023; 14():1117644. PubMed ID: 36819064
[TBL] [Abstract][Full Text] [Related]
60. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction.
Cheng C; Tan J; Qian W; Zhang L; Hou X
Life Sci; 2018 Sep; 209():157-166. PubMed ID: 30096384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
